Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: A meta-analysis

Annals of Surgical Oncology

Volumn 15, Issue 1, 2008, Pages 60-68

  Rekhraj, Sushil ^a   Aziz, Omer ^a   Prabhudesai, Shirish ^a   Zacharakis, Emmanouil ^a   Mohr, Franziska ^a   Athanasiou, Thanos ^a   Darzi, Ara ^a   Ziprin, Paul ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer staging; Peritoneal lavage cytology

Indexed keywords

ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CELL COUNT; CELL HETEROGENEITY; COLORECTAL CANCER; COLORECTAL SURGERY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; TUMOR CELL;

ASCITIC FLUID; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL LAVAGE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 38049186412     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9591-5     Document Type: Article

References (57)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108
2. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323-32
3. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-52
4. Hutter RV. At last-worldwide agreement on the staging of cancer. Arch Surg 1987;122:1235-9
5. Jass JR, O'Brien MJ, Riddell RH, et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 2007
6. Merkel S, Mansmann U, Papadopoulos T, et al. The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III. Cancer 2001;92:2754-9
7. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002;236:416-21
8. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8
9. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583-96
10. Michelassi F, Vannucci L, Ayala JJ, et al. Local recurrence after curative resection of colorectal adenocarcinoma. Surgery 1990;108:787-92
11. Hansen E, Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387-93
12. Feezor RJ, Copeland EM, III, Hochwald SN. Significance of micrometastases in colorectal cancer. Ann Surg Oncol 2002;9:944-53
13. Carmignani CP, Sugarbaker TA, Bromley CM, et al. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 2003;22:465-72
14. Umpleby HC, Fermor B, Symes MO, et al. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659-63
15. Fermor B, Umpleby HC, Lever JV, et al. Proliferative and metastatic potential of exfoliated colorectal cancer cells. J Natl Cancer Inst 1986;76:347-9
16. Skipper D, Cooper AJ, Marston JE, et al. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987;74:1049-52
17. Uras C, Altinkaya E, Yardimci H, et al. Peritoneal cytology in the determination of free tumour cells within the abdomen in colon cancer. Surg Oncol 1996;5:259-63
18. Leather AJ, Gallegos NC, Kocjan G, et al. Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 1993;80:777-80
19. Aoki S, Takagi Y, Hayakawa M, et al. Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. J Exp Clin Cancer Res 2002;21:555-62
20. Ojima H, Sasaki S, Fujisawa T, et al. Utility of serosal stamp cytology as an indicator for high-risk peritoneal metastasis in colorectal cancer surgery. Hepatogastroenterology 2003;50:87-90
21. Leather AJ, Kocjan G, Savage F, et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994;37:814-9
22. Bentrem D, Wilton A, Mazumdar M, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005;12:347-53
23. Ribeiro U, Jr., Safatle-Ribeiro AV, Zilberstein B, et al. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg 2006;10:170-6, discussion
24. Rosenberg R, Nekarda H, Bauer P, et al. Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma. Br J Surg 2006;93:325-31
25. Benedet JL, Bender H, Jones H, III, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000;70:209-62
26. Kienle P, Koch M. Minimal residual disease in gastrointestinal cancer. Semin Surg Oncol 2001;20:282-93
27. Clarke. Cochrane reviewer's handbook 4.1.3. Oxford, UK: The Cochrane Library, 2001
28. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Onkologie 2000;23:597-602
29. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34
30. Egger M, Smith GD. Misleading meta-analysis. BMJ 1995;311:753-4
31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
32. Gozalan U, Yasti AC, Yuksek YN, et al. Peritoneal cytology in colorectal cancer: incidence and prognostic value. Am J Surg 2007;193:672-5
33. Kanellos I, Zacharakis E, Kanellos D, et al. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer. Colorectal Dis 2006;8:436-40
34. Lloyd JM, McIver CM, Stephenson SA, et al. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 2006;12:417-23
35. Baskaranathan S, Philips J, McCredden P, et al. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival. Dis Colon Rectum 2004;47:2076-9
36. Kanellos I, Demetriades H, Zintzaras E, et al. Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum 2003;46:535-9
37. Yamamoto S, Akasu T, Fujita S, et al. Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol 2003;33:33-7
38. Bosch B, Guller U, Schnider A, et al. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg 2003;90:882-8
39. Guller U, Zajac P, Schnider A, et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 2002;236:768-75
40. Vogel I, Francksen H, Soeth E, et al. The carcinoembryonic antigen and its prognostic impact on immunocytologically detected intraperitoneal colorectal cancer cells. Am J Surg 2001;181:188-93
41. Vogel P, Ruschoff J, Kummel S, et al. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum 2000;43:92-100
42. Wind P, Norklinger B, Roger V, et al. Long-term prognostic value of positive peritoneal washing in colon cancer. Scand J Gastroenterol 1999;34:606-10
43. Hase K, Ueno H, Kuranaga N, et al. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum 1998;41:1134-40
44. Schott A, Vogel I, Krueger U, et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;227:372-9
45. Broll R, Lembcke K, Stock C, et al. Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma. Langenbecks Arch Chir 1996;381:51-8
46. Ambrose NS, MacDonald F, Young J, et al. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer-can monoclonal antibodies do better? Eur J Surg Oncol 1989;15:99-102
47. Vogel P, Ruschoff J, Kummel S, et al. Immunocytology improves prognostic impact of peritoneal tumour cell detection compared to conventional cytology in gastric cancer. Eur J Surg Oncol 1999;25:515-9
48. To EM, Chan WY, Chow C, et al. Gastric cancer cell detection in peritoneal washing: cytology versus RT-PCR for CEA transcripts. Diagn Mol Pathol 2003;12:88-95
49. Lindemann F, Schlimok G, Dirschedl P, et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-9
50. Eisenberg B, Decosse JJ, Harford F, et al. Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer 1982;49:1131-4
51. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041-7
52. Benson AB, III, Choti MA, Cohen AM, et al. NCCN Practice Guidelines for Colorectal Cancer. Oncology 2000;14:203-12
53. Figueredo A, Charette ML, Maroun J, et al. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 2004;22:3395-407
54. Benson AB, III, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004;22:3408-19
55. Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006;24:4011-9
56. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 1991;34:723-7
57. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43(Suppl):S15-S25